Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasia of the Uterine Cervix”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Early research (Phase 1)Study completedNCT02914470
What this trial is testing

Carboplatin-cyclophosphamide Combined With Atezolizumab

Who this might be right for
Breast CancerCervix CancerOvarian Cancer+1 more
The Netherlands Cancer Institute 12
Testing effectiveness (Phase 2)UnknownNCT02492503
What this trial is testing

Effectiveness of Chemotherapy in Metastatic or Recurrent Carcinoma Cervix

Who this might be right for
Metastatic Carcinoma to the Uterine CervixRecurrent Carcinoma CervixCervix Carcinoma Recurrent
All India Institute of Medical Sciences 40
Not applicableWithdrawnNCT04985357
What this trial is testing

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

Who this might be right for
Stage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more
Travera Inc
Not applicableStudy completedNCT05742711
What this trial is testing

Efficacy of PENS of the Auricle as an Opioid Sparing Postoperative Analgesic Technique in Cancer Endometrium and Cancer Cervix Patients

Who this might be right for
Cancer of EndometriumCancer of Cervix
DyAnsys, Inc. 48
Not applicableActive Not RecruitingNCT07735039
What this trial is testing

Dual-Modality Immunotherapy for HPV Clearance (DUAL-HPV)

Who this might be right for
Human Papillomavirus InfectionCervical Intraepithelial Neoplasia (CIN)Low-Grade Squamous Intraepithelial Lesions
Dr. Lutfi Kirdar Kartal Training and Research Hospital 76
Not applicableUnknownNCT06371118
What this trial is testing

HPV Self-sampling for Women Who do Not Attend Cervical Cancer Screening Programme

Who this might be right for
Papillomavirus InfectionsEarly Detection of CancerCervix Cancer+1 more
Universidade do Porto 1,000
Early research (Phase 1)Study completedNCT02164461
What this trial is testing

Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer

Who this might be right for
Effects of ImmunotherapyMetastatic/Recurrent Cervical CancerCervical Adenocarcinoma+6 more
Advaxis, Inc. 12
Not applicableStudy completedNCT02280967
What this trial is testing

Prevention of HPV in the School Health Service

Who this might be right for
Human PapillomavirusCervix Cancer
Uppsala University 832
Not applicableStudy completedNCT06252012
What this trial is testing

The Effect of Cervical Cancer Awareness Education Based on Mobile Application

Who this might be right for
Cervix CancerCancer AwarenessMobile Application+2 more
Kutahya Health Sciences University 120
Not applicableActive Not RecruitingNCT02328872
What this trial is testing

Compass - Randomised Controlled Trial of Primary HPV Testing for Cervical Screening in Australia

Who this might be right for
Cancer of the CervixCervical Intraepithelial Neoplasia
VCS Foundation 76,181
Testing effectiveness (Phase 2)Study completedNCT00285207
What this trial is testing

Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix

Who this might be right for
Cervical Intraepithelial NeoplasiaUterine Cervical Dysplasia
Tigris Pharmaceuticals 147
Not applicableLooking for participantsNCT05938192
What this trial is testing

Multimodality Treatments of HPV-related Lesions of the Female Genital Tract

Who this might be right for
HPVCervical CancerCervix Lesion+1 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 200